HOME >> MEDICINE >> NEWS
A threatened St. Johns wort plant could be more effective as an anti-depressant, Cornell and USDA researchers find

ver, not all St. John's wort products are the same. Previous studies have shown that the amount of hypericin in the plant - although usually labeled can vary from plant to plant, manufacturer to manufacturer, bottle to bottle and pill to pill. Thus Sirvent and Gibson are trying to determine how much of a role pre-harvest factors play in chemical differences. They are examining factors such as light, moisture, altitude and latitude; the plant parts; the plant's development stage; and the harvesting and handling practices that might affect the quality of the final product. Additionally, variations in St. John's wort products sometimes occur because manufacturers mix species of H. perforatum.

The plant typically is gathered as a weedy species in the western United States, but some is being grown commercially in the Pacific Northwest. It also is found along roadways and in fields in the eastern United States. Hypericin is concentrated in little black nodules nearly imperceptible to the untrained eye that adorn the floral edges and the plant's leaves. Curiously, St. John's wort is considered a noxious weed that can cause hypericism, or blistering and dyeing of an animal's skin when it is eaten. Its scraggly, almost frail-looking stem produces a brilliant yellow flower cluster and it grows readily in rock quarries and in marginal areas such as roadsides, where little else grows.


'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
14-Aug-2000


Page: 1 2

Related medicine news :

1. Caregivers refuse Alzheimers medications when patients quality of life threatened
2. Johns Hopkins scientists receive presidential medals
3. Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease
4. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
5. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
6. Johns Hopkins To Announce AIDS Capitated Care Program
7. Success of liver transplantation may be most influenced by three risk factors
8. Tracking trends in cochlear implant complications using a federal database
9. Alcohol relapse adversely affects 10-year liver transplant survival
10. Donor age has no affect on long-term liver transplant survival
11. Age shouldnt be a factor in kidney transplantation

Post Your Comments:
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss ... fastest fat loss program ever developed. It promises to provide ... There is no wonder after all that this has become ... new nutrition and workout fat loss program was created by ... According to the author of this fat loss system, the ...
(Date:10/31/2014)... Lee's Summit, Missouri (PRWEB) October 31, 2014 ... circulated the country about families narrowly escaping carbon monoxide ... winter season) looms just weeks away, one family-owned, Missouri-based ... and straightforward approach to making sure families start the ... systems are safe and secure. , Beginning Nov. ...
(Date:10/31/2014)... 2014 Energy Textiles has recently added ... gear is now available online, and Energy Textile is ... Celliant infrared-active athletic gear over compression gear. , ... has been signed for Under Armour to provide team ... eight years. In light of this decision, Energy Textiles ...
(Date:10/31/2014)... (HealthDay News) -- Obesity increases the risk of certain ... women, two new U.S. studies show. One study ... or obese increased the risk for estrogen receptor-negative and ... known this for a long time for white women, ... women," study author Esther John, a senior research scientist ...
(Date:10/31/2014)... of four older Americans say that either they or ... treatment, according to the latest issue of The Gerontological ... ( PP&AR ), which goes on to show ... fail to honor patients, end-of-life health care wishes. , ... Issues and Options ," features 12 articles that present ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Advance directives can benefit patients, families, and health care system 2
(Date:10/31/2014)... Oct. 31, 2014  Zebra Imaging, Inc., the ... announced today a strategic partnership with the Zygote ... 3D anatomy and biomedical models for animation and ... education markets.  Zygote maintains the world,s most comprehensive ... and has pioneered development of high-end solid 3D ...
(Date:10/31/2014)... , October 31, 2014 ... a clinical-stage pharmaceutical company focused on the development ... company will host a conference call to discuss ... trial of ORMD-0801, the company,s proprietary oral insulin ... November 3, 2014 at 10:00 a.m. Eastern time. ...
(Date:10/31/2014)... , Oct. 31, 2014  Zacks.com announces the list of stocks ... analysts discuss the latest news and events impacting stocks and the ... AMGN - Free Report ), Celgene (Nasdaq: ... BIIB - Free Report ), Market Vectors Biotech ETF ... S&P Biotech ETF (AMEX: XBI - Free Report ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
Cached News: